F/M Emerald Life Sciences Innovation ETF (LFSC) Dividend Yield, History & Forecast

F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund (ETF) listed on the NASDAQ Global Select. market capitalization is approximately $122M.

LFSC fund composition

LFSC holds 44 positions, with 55.7% of assets in its ten largest. It charges an expense ratio of 0.79%, and manages $121.0M.

Top 10 holdings

HoldingWeight
REPLReplimune Group Inc10.06%
LIVNLivaNova PLC7.04%
COGTCogent Biosciences Inc5.83%
TVTXTravere Therapeutics Inc5.75%
GHGuardant Health Inc5.36%
BLLNBilliontoone Inc4.97%
CORTCorcept Therapeutics Inc4.62%
SYRESpyre Therapeutics Inc4.10%
MANEVeraDermics Inc3.99%
UTHRUnited Therapeutics Corp3.99%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about F/M Emerald Life Sciences Innovation ETF (LFSC)

What does F/M Emerald Life Sciences Innovation ETF invest in?
The F/M Emerald Life Sciences Innovation ETF (LFSC) strategically invests in pioneering life science enterprises. Its core objective is to identify companies that are well-positioned for substantial long-term growth and the creation of significant value. As an actively managed fund, LFSC benefits from a highly specialized and experienced team dedicated to conducting in-depth research into complex life sciences firms. The fund primarily targets U.S. equity securities, selecting those that demonstrate strong growth potential. Specific criteria for inclusion involve a company's leadership in...